SCHEMBL8285333

SCHEMBL8285333

COCCOc1cc2c(cn1)c(=O)cc(Nc1ccccc1)n2-c1ccccc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 3/20 0.36
CDK4 P11802 2/20 0.36
CCND1 P24385 2/20 0.36
CCND2 P30279 2/20 0.36
CCND3 P30281 2/20 0.36
BTK Q06187 3/20 0.36
EGFR P00533 2/20 0.36
ITK Q08881 2/20 0.36
CYP1A2 P05177 5/20 0.35
CLK4 Q9HAZ1 2/20 0.35
MAPK1 P28482 2/20 0.35
LMNA P02545 2/20 0.35
CASP7 P55210 5/20 0.35
USP2 O75604 4/20 0.35
CASP1 P29466 4/20 0.35
HIF1A Q16665 4/20 0.35
CYP3A4 P08684 3/20 0.35
MEN1 O00255 2/20 0.35
CYP2C9 P11712 2/20 0.35
KMT2A Q03164 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8285261 0.88 GSK3B (0.38) GSK3BCDK4CCND1CCND2CCND3
SCHEMBL8287576 0.88 GSK3B (0.39) GSK3BCDK4CCND1CCND2CCND3
SCHEMBL8287459 0.85 GABRP (0.38) GSK3BCDK4CCND1CCND2CCND3
SCHEMBL8287240 0.84 HTT (0.41) GSK3BCDK4CCND1CCND2CCND3
SCHEMBL8285329 0.84 GSK3B (0.40) GSK3BCDK4CCND1CCND2CCND3
SCHEMBL8286470 0.84 KCNH3 (0.40) GSK3BCDK4CCND1CCND2CCND3
SCHEMBL8285335 0.83 MAT2A (0.37) GSK3BCDK4CCND1CCND2CCND3
SCHEMBL8285316 0.83 PDE11A (0.40) GSK3BCDK4CCND1CCND2CCND3
SCHEMBL8287482 0.83 GSK3B (0.40) GSK3BCDK4CCND1CCND2CCND3
SCHEMBL8287498 0.83 GSK3B (0.37) GSK3BCDK4CCND1CCND2CCND3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed